Dube Eric M

CIK 00017634942 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001763494

Recent Transactions

50 trades

Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-17$23.34/sh+108,493→ 541,379 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-09-17−108,493→ 0 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-17$64.95/sh−6,802→ 432,886 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-17$64.59/sh−101,691→ 439,688 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-16$23.34/sh+195,841→ 628,727 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-16$63.26/sh−99,716→ 529,011 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-09-16−195,841→ 108,493 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-16$63.64/sh−96,125→ 432,886 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-15$65.31/sh−270→ 432,886 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-09-15−95,666→ 304,334 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-15$61.99/sh−63,498→ 465,054 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-15$62.66/sh−28,796→ 436,258 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-15$23.34/sh+95,666→ 528,552 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-15$63.64/sh−3,102→ 433,156 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-06$43.95/sh−22,500→ 432,886 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-04+22,500→ 455,386 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2026-05-04−22,500→ 22,500 total
Award
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2026-05-04+45,000→ 45,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-15$41.75/sh−7,165→ 432,906 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-15$42.66/sh−20→ 432,886 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-15$41.01/sh−56,815→ 440,071 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-13+64,000→ 496,886 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-01$15.46/sh+60,000→ 492,886 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-01$31.46/sh−25,098→ 432,886 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-04-01−60,000→ 0 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-01$30.55/sh−34,902→ 457,984 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-02-20$30.10/sh−60,000→ 432,886 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-02-20$15.46/sh+60,000→ 492,886 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-02-20−60,000→ 60,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-02-03$32.06/sh−66,452→ 466,521 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-02-03$32.70/sh−33,635→ 432,886 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-01-31+113,800→ 532,973 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-01-31+303,600→ 303,600 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-01-27$15.46/sh+51,865→ 471,038 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-01-27−51,865→ 120,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-01-27$30.10/sh−51,865→ 419,173 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-01-23−8,135→ 171,865 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-01-23$30.01/sh−8,135→ 419,173 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-01-23$15.46/sh+8,135→ 427,308 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-10-29−27,128→ 180,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-10-29$30.12/sh−27,128→ 419,173 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-10-29$15.46/sh+27,128→ 446,301 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-10-28−92,872→ 207,128 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-10-28$30.38/sh−92,872→ 419,173 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-10-28$15.46/sh+92,872→ 512,045 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-05-05$21.05/sh−18,924→ 419,173 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-05-02+18,924→ 438,097 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2025-05-02−18,924→ 18,924 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$24.04/sh−11,375→ 419,173 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-03$20.21/sh−50,691→ 430,548 total

Companies

Recent Filings

Address

C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DR., SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov